Literature DB >> 11359670

Recent developments in the regulation of peripheral blood stem cell mobilization and engraftment by cytokines, chemokines, and adhesion molecules.

Y Gazitt1.   

Abstract

Peripheral blood stem cells (PBSC) have become the preferred source of stem cells for autologous transplantation because of the technical advantage and the shorter time to engraftment. Administration of hematopoietic growth factors such as granulocyte colony-stimulating factor (G-CSF) or granulocyte-macrophage colony-stimulating factor (GM-CSF) results in mobilization of PBSCs into the peripheral blood. G-CSF and GM-CSF differ somewhat in the number and composition of CD34(+) cells and effector cells mobilized to the peripheral blood; however, the molecular mechanism underlying the release and engraftment of CD34(+) cells by these growth factors is poorly understood. This review provides a recent update on the involvement of hematopoietic growth factors, chemokines, adhesion molecules, and chemokine receptors in the regulation of stem cell release and engraftment. The involvement of very late antigen-4 (VLA-4), VLA-5, leukocyte function associated-1 molecule (LFA-1), and L-selectin and their receptors CXCR4 and its ligand SDF-1 will be discussed, and cross talk between these factors will also be reviewed in the context of stem cell release and engraftment. Finally, PBSC mobilization by chemokines will be reviewed in relation to hematopoietic growth factors.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11359670     DOI: 10.1089/15258160151134908

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  6 in total

Review 1.  Chemokines in multiple myeloma.

Authors:  Rohit Aggarwal; Irene M Ghobrial; G David Roodman
Journal:  Exp Hematol       Date:  2006-10       Impact factor: 3.084

Review 2.  The impact of redox and thiol status on the bone marrow: Pharmacological intervention strategies.

Authors:  Christina L Grek; Danyelle M Townsend; Kenneth D Tew
Journal:  Pharmacol Ther       Date:  2010-10-15       Impact factor: 12.310

3.  The lineage-c-Kit+Sca-1+ cell response to Escherichia coli bacteremia in Balb/c mice.

Authors:  Ping Zhang; Steve Nelson; Gregory J Bagby; Robert Siggins; Judd E Shellito; David A Welsh
Journal:  Stem Cells       Date:  2008-05-15       Impact factor: 6.277

4.  Acute alcohol intoxication inhibits the lineage- c-kit+ Sca-1+ cell response to Escherichia coli bacteremia.

Authors:  Ping Zhang; David A Welsh; Robert W Siggins; Gregory J Bagby; Caroline E Raasch; Kyle I Happel; Steve Nelson
Journal:  J Immunol       Date:  2009-02-01       Impact factor: 5.422

Review 5.  The dark side of granulocyte-colony stimulating factor: a supportive therapy with potential to promote tumour progression.

Authors:  Belinda Yeo; Andrew D Redfern; Kellie A Mouchemore; John A Hamilton; Robin L Anderson
Journal:  Clin Exp Metastasis       Date:  2018-07-02       Impact factor: 5.150

6.  A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.

Authors:  Chitra Hosing; Mark F Munsell; James M Reuben; Uday Popat; Bang-Ning Lee; Hui Gao; Martin Körbling; Elizabeth J Shpall; Partow Kebriaei; Amin Alousi; Marcos De Lima; John McMannis; Muzaffar Qazilbash; Paolo Anderlini; Sergio Giralt; Richard E Champlin; Issa Khouri
Journal:  J Blood Med       Date:  2010-04-14
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.